Bio Rad Laboratories, Inc. financial data

Symbol
BIO, BIO-B on NYSE
Industry
Laboratory Analytical Instruments
Location
1000 Alfred Nobel Drive, Hercules, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Oct 31, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 619 % +11.9%
Quick Ratio 161 % +22.1%
Debt-to-equity 41 % +0.37%
Return On Assets -6.89 % -452%
Operating Margin 11.9 % -10.7%

Shares

Label TTM Value / Value Unit Change %
Weighted Average Number of Shares Outstanding, Basic 27.9M shares -3.96%
Weighted Average Number of Shares Outstanding, Diluted 28M shares -4.24%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 2.58B USD -5.15%
Research and Development Expense 280M USD +12.2%
Operating Income (Loss) 306M USD -15.3%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -1.01B USD -437%
Income Tax Expense (Benefit) -227M USD -711%
Net Income (Loss) Attributable to Parent -779M USD -389%
Earnings Per Share, Basic -27.3 USD/shares -377%
Earnings Per Share, Diluted -27.3 USD/shares -367%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 410M USD -10.4%
Accounts Receivable, after Allowance for Credit Loss, Current 462M USD +0.99%
Inventory, Net 804M USD +3.67%
Other Assets, Current 28.2M USD +12.2%
Assets, Current 3.06B USD -2.9%
Property, Plant and Equipment, Net 529M USD +6.1%
Operating Lease, Right-of-Use Asset 174M USD -13.1%
Intangible Assets, Net (Excluding Goodwill) 307M USD -2.18%
Goodwill 415M USD +2%
Other Assets, Noncurrent 94.9M USD +0.27%
Assets 10.6B USD -10.9%
Accounts Payable, Current 122M USD +9.23%
Employee-related Liabilities, Current 146M USD -5.76%
Liabilities, Current 498M USD -10.8%
Long-term Debt and Lease Obligation 1.2B USD +0.11%
Deferred Income Tax Liabilities, Net 1.08B USD -21.4%
Operating Lease, Liability, Noncurrent 144M USD -13.9%
Other Liabilities, Noncurrent 198M USD +6.18%
Liabilities 3.12B USD -10.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax -315M USD +36.6%
Retained Earnings (Accumulated Deficit) 8.13B USD -8.74%
Stockholders' Equity Attributable to Parent 7.49B USD -11%
Liabilities and Equity 10.6B USD -10.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 69.8M USD -28.9%
Net Cash Provided by (Used in) Financing Activities 4.31M USD -99.6%
Net Cash Provided by (Used in) Investing Activities -43.1M USD +38.9%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 29.4M USD -1.92%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 412M USD -10.1%
Interest Paid, Excluding Capitalized Interest, Operating Activities 22.4M USD -0.25%
Deferred Tax Assets, Valuation Allowance 53.2M USD -26.9%
Deferred Tax Assets, Gross 264M USD -1.75%
Operating Lease, Liability 187M USD -9.5%
Payments to Acquire Property, Plant, and Equipment 40.2M USD +12.5%
Lessee, Operating Lease, Liability, to be Paid 212M USD -10.5%
Property, Plant and Equipment, Gross 1.6B USD +5.82%
Operating Lease, Liability, Current 42.8M USD +9.51%
Lessee, Operating Lease, Liability, to be Paid, Year Two 37.3M USD -12.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 49M USD +7.69%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 25.5M USD -17.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 28.8M USD -7.69%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 7.5M shares
Unrecognized Tax Benefits 88.5M USD -3.8%
Lessee, Operating Lease, Liability, to be Paid, Year Four 22.2M USD -10.1%
Operating Lease, Payments 42.9M USD +6.45%
Additional Paid in Capital 448M USD +2.02%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 21.8M USD -9.92%
Deferred Tax Assets, Net of Valuation Allowance 211M USD +7.61%
Interest Expense 49.1M USD +0.65%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares